Stamelou Maria

Stamelou Maria Neurologist

Head of Parkinson & Movement Disorders Department HYGEIA

Education & Academic Qualifications

  • Associate Professor of Neurology, Philipps University, Marburg, Germany
  • 10/2010-02/2013 Out-patient clinic for Movement Disorders and Botulinum toxin injections; Sobell Department of Movement Neuroscience, Institute of Neurology, UCL, Queen Square, London, UK
  • 2005 – 2010 Residency in Neurology, Philipps – University, Marburg, Germany
  • 2009 – 2010 Out-patient clinic for Botulinum toxin injections in dystonia, spasticity and hyperhidrosis (certified by the german society for Botulinum toxin injections)
  • 2007 – 2009 ICU for neurological disorders
  • 2005 – 2010 Out-patient clinic for Movement Disorders, specialized clinic for Parkinson’s disease and atypical parkinsonian syndromes
  • 2005 – 2009 PhD student to Prof. W. H. Oertel, Philipps – University, Marburg, Germany
  • 1996- 2002 Medical studies, Aristoteleion University of Thessaloniki, Greece


Doctoral thesis

  • 01/2005 – 09/2009 “Coenzyme Q10 in progressive supranuclear palsy: a randomized, double-blind, placebo-controlled study” (PUM, Germany, “summa cum laude)”

Fellowship in Societies, Membership in Journal Editorial Committees

  • PSP study group for the revision of clincial criteria for PSP, supported by MDS 

  • Tremor task force for the classification of tremor disorders, MDS 

  • International Movement Disorders Society 

  • Americal Academy of Neurology (AAN) 

  • European Neurological Society/ European Federation of Neurological Society 

  • Ελληνική Νευρολογική Εταιρεία

  • German Parkinson Study Group 

  • German Association for Botulinum Toxin Therapy 

  • German PSP Study Group

Editorial Boards:

  • Movement Disorders Journal (Assistant Editor), since Dec 2013 

  • Frontiers in Movement Disorders (Editorial Board), since 2013

AD-HOC REVIEWER for peer-reviewed international journals:

  • Lancet Neurology 

  • PLOS one

  • Cerebral Cortex 

  • American Journal of Neuroradiology 

  • Journal of Neurological Sciences

  • Neuroepidemiology

  • Journal of Neurology, Neurosurgery and Psychiatry

  • CNS & Neurological Disorders

  • Parkinsonism and Related Disorders 

  • Movement Disorders Cinical Practice 

  • Journal of Alzheimer disease 

  • Clinical Genetics 

  • Movement Disorders Journal


Work Experience

  • Since 2013 Second Dept. of Neurology, University of Athens, Parkinson’s disease and movement disorders out-patient clinics 

  • Since 2013 Private practice for Parkinson’s disease and movement disorders patients 

  • 2010-2013 Movement disorders clinics, and Botulinum toxin clinics, UCL, Queen Square, London, UK 

  • 2005-2010 Neurology Residency, Philipps-University, Μarburg,Germany 

  • 2003-2004 Hospital of Corinth, internal medicine residency

Education Experience:

  • Under-and post-graduate teaching for medical students in the University of Marburg since 2005 

  • Under-graduate and neurology trainees teaching Second Department of Neurology, Univ. of Athens, since 2013


Clinical & Research Interest

  • Parkinson’s disease

  • Atypical parkinsonian conditions (progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration 

  • Dystonias

  • Tics 

  • Choreas (Huntington’sdisease and others) 

  • Myoclonus

  • Tremor disorders 

  • Ataxias 

  • Stiff-person syndrome

Research Interest:

  • Clinical research in Parkinson’s disease 

  • Clinical research in progressive supranuclear palsy (PSP) and other atypical parkinsonian conditions 

  • Clinical and genetic studies in familial complicated movement disorders 

  • Clinical research in familial Parkinson’s disease, in particular in patients with mutations in the a-synuclein gene


Honors & Awards

  • 2006-2007 Fellowship of the Hellenic Neurological Society (ENE) as a PhD student, Philipps – University Marburg, Germany

  • 2009 PhD with excellent distinction (summa cum laude), Philipps – University, Marburg, Germany 

  • 2009 MLP – dissertation price for the best dissertation in human medicine 2009, Germany

  • 2009 Freundlich – Stiftung for “Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial”, Germany 

  • 2009 Award from the Philipps-University, Marburg for the best dissertation in human medicine 

  • 2010-2011 EFNS Scientific Fellowship from the European Federation of Neurological Societies



  • Stamelou M, Edwards MJ, Quinn N, Bhatia KP: Parkinson’s disease and other movement disorders, Oxford Specialists Handbooks in neurology, Oxford University Press, 2016

  • Stamelou M, Erro R, Bhatia K: Case studies in Movement Disorders, Cambridge University Press, in preparation 

  • Christ H, Stamelou M, Hoglinger GU. Die Medizinischen Grundlagen der Progressiven Supranuklearen Blickparese. In: Wagner S, Kotz S (Hrg.). Progressive Supranukleare Blickparese (PSP) – Sprechen, Sprache, Kommunikation. Leipzig 2009 

  • Hoglinger GU, Oertel WH, Stamelou M. Progressive Supranukleare Blickparese: in Parkinson-Syndrome und andere Bewegungsstorungen-Oertel, Deuschl, Poewe. Thieme Verlag, 2012 p:138-151 

  • Hoglinger GU, Oertel WH , Stamelou M. Kortikobasale Degeneration: in Parkinson-Syndrome und andere Bewegungsstorungen -Oertel, Deuschl, Poewe. Thieme Verlag, 2012 p: 151-159 

  • Bhatia KP, Stamelou M, Bressman S. Dystonia: and overview, Oxford Textbook of Movement Disorders, Oxford University Press, 2013 

  • Stamelou M, Bhatia KP. Dementia in Parkinson’s disease and atypical parkinsonism, In Dementia in Movement Disorders, Merello, Springer, in press

  • Erro R, Stamelou M, Bhatia KP. Paroxysmal movement disorders In Parkinson’s Disease and Movement Disorders. Jankovic, Tolosa, Wolters Kluwer Health —Lippincott Williams & Wilkins


Recent Publications

International Congresses:

  • Interventions in PSP: World congress on Parkinson’s disease and related disorders: Milan, Italy, 6-9 December 2015

  • Unusual Movement Disorders, Video Session. World congress on Parkinson’s disease and related disorders: Milan, Italy, 6-9 December 2015

  • PSP subtypes and phenotypes. World congress on Parkinson’s disease and related disorders: Milan, Italy, 6-9 December 2015

  • Update PSP/MSA. 2nd Congress of the European Academy of Neurology: Copenhagen, Denmark, 28-31 May 2016

  • Movement Disorders Grand rounds: 20th International Parkinson’s disease and Movement Disorders Congress, Berlin, Germany, 18-23 June 2016

  • The role of gastrointestinal system in the pathogenesis of PD. 11th World congress on controversies in Neurology, 25-29 March 2017

  • Is essential tremor a single entity? 11th World congress on controversies in Neurology, 25-29 March 2017

  • Distinguishing PSP, MSA and CBS, 2nd EAN congress, Amsterdam, June, 2017

  • Treatment of non-motor symptoms in Parkinson’s disease, 3rd EAN congress, Lisbon, 2018

120 puplications at international magazines, t hemost recent below :

  • Transducer-based evaluation of tremor. Haubenberger D, Abbruzzese G, Bain PG, Bajaj N, Benito-Leon J, Bhatia KP, Deuschl G, Forjaz MJ, Hallett M, Louis ED, Lyons KE, Mestre TA, Raethjen J, Stamelou M, et al.Mov Disord. 2016 Jun 6. 

  • Atypical parkinsonism – new advances. Stamelou M, Bhatia KP. Curr Opin Neurol. 2016 Jun 6. 

  • A Review of Treatment Options for Progressive Supranuclear Palsy. Stamelou M, Hoglinger G. CNS Drugs. 2016 May 24.

  • Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study. Papadimitriou D, Antonelou R, Miligkos M, Maniati M, Papagiannakis N, Bostantjopoulou S, Leonardos A, Koros C, Simitsi A, Papageorgiou SG, Kapaki E, Alcalay RN, Papadimitriou A, Athanassiadou A, Stamelou M, Stefanis L.Mov Disord. 2016 Mar 29. 

  • Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Stamelou M, Schope J, Wagenpfeil S, et al., Tauros Investigators, and MDS-Endorsed PSP Study Group. Mov Disord. 2016 May;31(5):742-7. 

  • The clinical syndrome of dystonia with anarthria/aphonia. Ganos C, Crowe B, Stamelou M, et al. Parkinsonism Relat Disord. 2016 Mar;24:20-7. 

  • Experimental pain sensitivity in multiple system atrophy and Parkinson’s disease at an early stage. Mylius V, Pee S, Pape H, Teepker M, Stamelou M, et al. Eur J Pain. 2016 Feb 23.

  • Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes. Valadas A, Contarino MF, Albanese A, Bhatia KP, Falup-Pecurariu C, Forsgren L, Friedman A, Giladi N, Hutchinson M, Kostic VS, Krauss JK, Lokkegaard A, Marti MJ, Milanov I, Pirtosek Z, Relja M, Skorvanek M, Stamelou M, et al. Eur J Neurol. 2016 Apr;23(4):772-9. 

  • Lower urinary tract dysfunction in patients with functional movement disorders. Batla A, Parees I, Edwards MJ, Stamelou M, Bhatia KP, Panicker JN. J Neurol Sci. 2016 Feb 15;361:192-4.

  • Late-onset cerebellar ataxia: Do not forget Friedreich’s. Stamelou M. Mov Disord. 2016 Jan;31(1):7-8.

  • Ricciardi L, Edwards MJ, Fasano A, Bhatia KP, Stamelou M. Progressive spasticity, supranuclear gaze palsy and postural instability, without parkinsonism: what’s in a phenotype?J Neurol Sci. 2018 Jul 15;390:84-86. 

  • Stamelou M, Petrucci S, Ginevrino M, Pons R, Papagiannakis N, Stefanis L, Valente EM. Intrafamilial variability in a polish family harbouring a frameshift THAP1 mutation.J Neurol Sci. 2018 May 15;388:158. 

  • Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G; Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society.Mov Disord. 2018 Jan;33(1):75-87

  • Obeso JA, Stamelou M, et al.. Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy.Mov Disord. 2017 Sep;32(9):1264-1310.